Smart Pills Market Size, Share, Future Analysis, 2026-2034

Market Overview

According to fortune business insights, the global smart pills market size was valued at USD 2.37 billion in 2025. The market is projected to grow from USD 2.55 billion in 2026 to USD 4.11 billion by 2034, exhibiting a CAGR of 6.2% during the forecast period. North America dominated the smart pills market with a market share of 40.08% in 2025.

The latest research report on the “Smart Pills Market, 2026-2034” provides a detailed analysis of these insights.

The analysis shows that top companies are investing more in smart pills due to the rising prevalence of chronic conditions and the growing demand for minimally invasive diagnostics. For instance, major players such as Medtronic and Olympus Corporation are advancing capsule endoscopy products through significant research and development. This trend indicates strong demand for smart pill technology worldwide.

Major Players Profiled in the Market Report:

• Medtronic (U.S.)

• Olympus Corporation (Japan)

• CapsoVision, Inc. (U.S.)

• INTROMEDIC (South Korea)

• JINSHAN Science & Technology (China)

• AnX Robotics (U.S.)

• etectRx (U.S.)

• Shenzhen Zifu Medical Technology Co., Ltd. (China)

• Ankon Technologies (Wuhan) Co., Ltd. (China)

Segments

Rising Diagnostic Procedures to Propel Diagnostic Imaging Segment GrowthBased on application, the market is divided into diagnostic imaging, drug delivery, and patient monitoring. The diagnostic imaging segment holds the largest market share and dominates the market owing to the growing prevalence of chronic conditions, leading to a rising number of diagnostic procedures and demand for smart pills globally.

Increasing Prevalence of GI Disorders to Drive Gastrointestinal Disorders Segment ExpansionBy disease indication, the market is categorized into gastrointestinal disorders, cancer, neurological disorders, and others. The gastrointestinal disorders segment is leading the market due to the increasing prevalence of conditions like Crohn’s disease, which drives the demand for capsule endoscopy and other smart pill solutions.

Hospitals & ASCs to Dominate the Market Due to Rising Number of FacilitiesBased on end-user, the market is segmented into hospitals & ASCs, specialty clinics, and others. The hospitals & ASCs segment holds the largest market share owing to the growing number of these facilities and the rising prevalence of chronic conditions that require advanced diagnostic procedures.

For detailed market insights: https://www.fortunebusinessinsights.com/smart-pills-market-103122

Report Coverage

The report offers:

• Major growth drivers, restraining factors, opportunities, and potential challenges for the market.

• Comprehensive insights into regional developments.

• List of major industry players.

• Key strategies adopted by the market players.

• The latest industry developments include product launches, partnerships, mergers, and acquisitions.

Drivers & Restraints

Increasing Prevalence of Chronic Disorders to Propel Market GrowthThe rapid growth in chronic diseases, including cancer and gastrointestinal disorders, has raised the demand for minimally invasive diagnostic solutions among patients. This, coupled with growing investments in advanced remote patient monitoring and early detection technologies, is boosting the smart pills market growth.

However, the high device and procedure costs, along with inadequate reimbursement frameworks in some regions, may hamper market growth by making it challenging for patients and smaller healthcare facilities to adopt these advanced technologies.

Regional Insights

Strong Clinical Adoption in the U.S. Propels Market Growth in North AmericaNorth America holds the dominant smart pills market share and is projected to experience growth during the forecast period. The region’s growth is attributed to the increasing prevalence of chronic conditions, strong clinical adoption and trials, and a well-established healthcare infrastructure.

Asia Pacific is one of the fastest-growing regions in the market. The growth is attributed to large patient populations, rising healthcare access, and increasing investments in healthcare infrastructure.

Smart Pills Market Future Growth:

The smart pills market is experiencing robust growth, fueled by technological advancements, the rising prevalence of chronic diseases, and a strong shift toward minimally invasive and remote patient monitoring. Today's providers are increasingly drawn to next-generation ingestible devices that incorporate AI-driven software, high-resolution imaging, and multi-sensor capabilities for pH, pressure, and temperature monitoring. Additionally, there's growing interest in their application for controlled drug delivery and digital therapeutics. The expansion of healthcare expenditure and organized screening programs are also key growth drivers. While North America continues to dominate the market, the Asia-Pacific region is seeing a surge in demand due to large patient populations and improving healthcare access.

Competitive Landscape

Adoption of Growth Strategies to Propel Market GrowthThe market features prominent players like Medtronic and Olympus Corporation. These leading companies are accelerating growth through strategic initiatives such as maintaining a robust product portfolio, focusing on inorganic growth strategies, and launching novel products to increase adoption. Their proactive approach to innovation and strengthening their brand presence continues to fuel the market’s momentum.

Key Industry Development

• November 2025: CapsoVision, Inc. submitted an application to the U.S. FDA for Breakthrough Device Designation (BDD) for its CapsoCam UGI capsule endoscopy system for early-stage pancreatic cancer detection.

• June 2025: Researchers at the California Institute of Technology developed a smart capsule called PillTrek, capable of measuring pH, temperature, and various biomarkers to provide novel diagnostic solutions.

• May 2025: AnX Robotica received FDA 510(k) approval for MotiliCap and its companion software, MotiliScan, an advanced, non-invasive tool for assessing whole-gut transit times.

• January 2025: CapsoVision, Inc. received U.S. FDA approval for the CapsoCam Plus, a capsule endoscopy system designed for remote ingestion, strengthening its market presence.

• June 2024: USC Viterbi developed ingestible sensors that detect stomach gases and provide real-time location tracking, aiming to advance smart pill technology.

Explore Japan’s Market Opportunities - Latest Smart Pills Market Insights